KAMADA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,977 ILa | -1.15% |
|
-3.23% | -11.23% |
| 05-08 | Transcript : Kamada Ltd., Q1 2024 Earnings Call, May 08, 2024 | |
| 05-08 | Kamada Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 587M 158M 58.74B 215M | Sales 2025 * | 664M 179M 66.43B 243M | Capitalization | 1.14B 306M 114B 416M |
|---|---|---|---|---|---|
| Net income 2024 * | 55M 14.82M 5.5B 20.12M | Net income 2025 * | 66M 17.79M 6.6B 24.15M | EV / Sales 2024 * | 1.93 x |
| Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 1.71 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 378 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on Kamada Ltd.
More press releases
| 1 day | -1.15% | ||
| 1 week | -3.23% | ||
| Current month | -0.35% | ||
| 1 month | +3.56% | ||
| 3 months | -12.29% | ||
| 6 months | +13.30% | ||
| Current year | -11.23% |
1 week
1 971.00
2 085.00
1 month
1 909.002 200.00
Current year
1 872.002 338.00
1 year
1 685.002 338.00
3 years
1 309.002 338.00
5 years
1 309.004 500.00
10 years
1 160.004 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 13-12-08 |
David Tsur
FOU | Founder | 73 | 90-12-12 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 17-12-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 19-12-23 |
Leon Recanati
BRD | Director/Board Member | 76 | 05-04-30 |
David Tsur
FOU | Founder | 73 | 90-12-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.04% | 0 M€ | 0.00% | - | |
| 0.01% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-19 | 1,977 | -1.15% | 25,811 |
| 24-05-16 | 2,000 | -2.91% | 46,444 |
| 24-05-15 | 2,060 | +0.83% | 44,176 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 19, 2024 at 08:49 am
More quotes
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Sector
Pharmaceuticals
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.23% | 306M | |
| -2.65% | 90.45B | |
| +3.68% | 41.45B | |
| -10.90% | 33.57B | |
| +58.05% | 25.73B | |
| -19.56% | 14.73B | |
| -9.06% | 12.82B | |
| -11.34% | 11.7B | |
| -43.53% | 11.44B | |
| +3.75% | 8.79B |
- Stock Market
- Equities
- KMDA Stock
